[{"id":"76dc685c-5180-45f9-a6c8-b0af7640db1b","acronym":"","url":"https://clinicaltrials.gov/study/NCT00923741","created_at":"2021-01-29T06:59:36.326Z","updated_at":"2024-07-02T16:37:09.193Z","phase":"Phase 1","brief_title":"Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT00923741","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e talactoferrin oral (oral rhLF)"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 06/19/2008","start_date":" 06/19/2008","primary_txt":" Primary completion: 02/01/2010","primary_completion_date":" 02/01/2010","study_txt":" Completion: 02/01/2010","study_completion_date":" 02/01/2010","last_update_posted":"2018-07-05"}]